Investigate / FTV
Understand Fortive Corp
Do Fortive's software, instrument and workflow offerings in industrial and healthcare settings hold up under weaker markets, supply disruption and competition?
Snapshot reviewed 2026-10-02. Source published 2026-07-29. No account needed.
AI-assisted synthesis of selected public filings, checked against the cited excerpts. Not a complete analysis.
This is a research starting point, not a buy/sell recommendation or a current valuation. New developments after these sources are not incorporated automatically.
Your research workspace / FTV
Ask better questions. Keep the evidence.
Explore the available sources for Fortive Corp, then keep what deserves another look.
01 Investor activity
Who reports owning FTV?
5 tracked reported owners. Disclosures are delayed and may describe different quarters—not live holdings or stated motives.
02 Business evidence
Reported evidence
What does the company do?
Customers pay for instruments, software and services that support mission-critical workflows, including maintenance, measurement, condition monitoring, asset lifecycle software, and connected worker safety and compliance.
Latticework interpretation
What could support the case?
If healthcare customers rely on these workflow solutions to meet safety standards and keep operating rooms performing, the offerings could be tied to important customer processes, which warrants further research.
Latticework interpretation
What could break the case?
If economic or market conditions weaken, demand for products, software and services could fall, with order cancellations, longer sales cycles and slower adoption of new technologies.
03 Questions to investigate
Open saved takeaways →Read the full company brief
1. Understand the business
Customers pay for instruments, software and services that support mission-critical workflows, including maintenance, measurement, condition monitoring, asset lifecycle software, and connected worker safety and compliance.
Source: Annual filing · business description ↗2. What the reported results show
Latest source: 10-Q, reporting period ended 2026-07-03. Selected reported US-GAAP/USD comparisons. The period and basis of each measure are shown separately; year-to-date cash flow is not a quarterly figure. Missing comparisons are collection gaps, not evidence that a company has no revenue or earnings.
Comparable figures are not available in this snapshot. Inspect the filing; missing data is not zero.
10-Q · latest checked financial statements and discussion ↗3. The investment debate
Latticework interpretation of the reported results—not the stated motives of any investor.
What could support the case
If healthcare customers rely on these workflow solutions to meet safety standards and keep operating rooms performing, the offerings could be tied to important customer processes, which warrants further research.
Supporting filing ↗The strongest caution
If economic or market conditions weaken, demand for products, software and services could fall, with order cancellations, longer sales cycles and slower adoption of new technologies.
Caution evidence ↗An interesting business is not necessarily an attractive investment at today's price. Price, dilution, financing terms and a valuation range still need investigation.
Inspect the evidence behind both sides ↗4. Three questions worth investigating
Use these to guide your research, not as conclusions that have already been proved.
How exposed is demand to end-market cyclicality?
Starting evidence: The company warns its growth could suffer if served markets decline, fail to grow as anticipated, or experience cyclicality.
Investigate next: Review segment results and order commentary across cycles to see which businesses weakened when end markets softened.
Read the supporting filing ↗How concentrated are supply risks?
Starting evidence: Reliance on sole or limited sources for certain materials, components and services could cause production interruptions, delays and inefficiencies.
Investigate next: Look for disclosure of which components rely on single sources and how past supply disruptions affected shipments and margins.
Read the supporting filing ↗What did the Ralliant separation change about the business?
Starting evidence: The Precision Technologies business was spun off and is reported as a discontinued operation, so continuing results cover only the remaining segments.
Investigate next: Compare continuing-operations results before and after separation, and examine any stranded costs or changes in capital allocation.
Read the supporting filing ↗5. Decide what to do next
Worth another look? Save this company and return to the evidence. Writing a private view is optional. You do not need to decide whether to invest today.
Save is on this device. Recording a private view requires sign-in and an explicit save. Neither action subscribes you to email or automatically evaluates your thesis.